This is the authors' abstract. We don't add key points for this paper.
Background: Diabetic ketoacidosis (DKA) is a life-threatening acute complication of diabetes mellitus (DM). Multimorbidity in Rheumatic Diseases(RDs) is well reported with many vital organs and systems often affected that complicates hospital care during acute illnesses. Understanding disease dynamics is vital to tailoring DKA management in patients with RDs in order to maximize patient outcomes. Outcomes of DKA in a patients with RDs is unknown. Objectives: We investigated the in-hospital outcomes of patients hospitalized for Diabetic ketoacidosis(DKA) and compared the same outcomes with patients who had DKA with underlying Rheumatologic Diseases. Methods: This is retrospective cohort study of a nationwide inpatient sample (NIS) database from 2015 to 2019. ICD-10 CM codes were used to identify adults (>18 yrs) with RDs. The primary outcomes were rates of in-hospital mortality, length of stay, total charges, major bleeding and needs for use of pressors and mechanical ventilation. Results: In the study period there were 1,134,550 patients hospitalized for Diabetic Ketoacidosis(DKA) in the United States, 16225 patients had Diabetic Ketoacidosis with Rheumatologic Diseases(DKA+RDs). The prevalence of DKA+RDs was highest (p<0.00001) among whites (68.32% vs. 57.25%) and smokers (40.72%). This group was in the higher income bracket (15.8% vs. 13.13% for $82000) and had insurance. Charlson Comorbidity Index showed higher number of comorbidities among DKA+RDs patients (p< 0.00001) including hypertension, CHF, CKD, alcohol use, liver disease, COPD, and thyroid disease. Inpatient mortality was significantly higher for DKA+RDs group (1.16% in DKA+RDs vs 0.92% in DKA patients), hospitalizations were 0.51 days longer (95% CI: 1-4.32, p=0.0001) and with $6284 higher total charges (p = 0.0001). Hospital stay in this group was significantly more complicated by major bleeding (5.03% in DKA+RDs vs 4.72% in DKA group; p<0.001) and intubation (4.05 in DKA+RDs vs 3.42% in DKA group; p<0.024) but not concomitant infection or sepsis. Conclusion: We found increased death rates and in-hospital complications for patients with RDs that are admitted for DKA. This incurs longer length of stay and higher hospital charges. Our study has several limitations including potential confounders and biases. This underscores the need for future research to include outcomes of DKA in individual RDs as well as long term outcomes.REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests: None declared.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jelić et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: